Literature DB >> 11743878

Structural analyses reveal two distinct families of nucleoside phosphorylases.

Matthew J Pugmire1, Steven E Ealick.   

Abstract

The reversible phosphorolysis of purine and pyrimidine nucleosides is an important biochemical reaction in the salvage pathway, which provides an alternative to the de novo purine and pyrimidine biosynthetic pathways. Structural studies in our laboratory and by others have revealed that only two folds exist that catalyse the phosphorolysis of all nucleosides, and provide the basis for defining two families of nucleoside phosphorylases. The first family (nucleoside phosphorylase-I) includes enzymes that share a common single-domain subunit, with either a trimeric or a hexameric quaternary structure, and accept a range of both purine and pyrimidine nucleoside substrates. Despite differences in substrate specificity, amino acid sequence and quaternary structure, all members of this family share a characteristic subunit topology. We have also carried out a sequence motif study that identified regions of the common subunit fold that are functionally significant in differentiating the various members of the nucleoside phosphorylase-I family. Although the substrate-binding sites are arranged similarly for all members of the nucleoside phosphorylase-I family, a comparison of the active sites from the known structures of this family indicates significant differences between the trimeric and hexameric family members. Sequence comparisons also suggest structural identity between the nucleoside phosphorylase-I family and both 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase and AMP nucleosidase. Members of the second family of nucleoside phosphorylases (nucleoside phosphorylase-II) share a common two-domain subunit fold and a dimeric quaternary structure, share a significant level of sequence identity (>30%) and are specific for pyrimidine nucleosides. Members of this second family accept both thymidine and uridine substrates in lower organisms, but are specific for thymidine in mammals and other higher organisms. A possible relationship between nucleoside phosphorylase-II and anthranilate phosphoribosyltransferase has been identified through sequence comparisons. Initial studies in our laboratory suggested that members of the nucleoside phosphorylase-II family require significant domain movements in order for catalysis to proceed. A series of recent structures has confirmed our hypothesis and provided details of these conformational changes. Structural studies of the nucleoside phosphorylases have resulted in a wealth of information that begins to address fundamental biological questions, such as how Nature makes use of the intricate relationships between structure and function, and how biological processes have evolved over time. In addition, the therapeutic potential of suppressing the nucleoside phosphorylase activity in either family of enzymes has motivated efforts to design potent inhibitors. Several research groups have synthesized a variety of nucleoside phosphorylase inhibitors that are at various stages of preclinical and clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11743878      PMCID: PMC1222293          DOI: 10.1042/0264-6021:3610001

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  136 in total

1.  The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue.

Authors:  M FRIEDKIN; D ROBERTS
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

2.  Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis.

Authors:  J D Stoeckler; A F Poirot; R M Smith; R E Parks; S E Ealick; K Takabayashi; M D Erion
Journal:  Biochemistry       Date:  1997-09-30       Impact factor: 3.162

Review 3.  Evolution of a biosynthetic pathway: the tryptophan paradigm.

Authors:  I P Crawford
Journal:  Annu Rev Microbiol       Date:  1989       Impact factor: 15.500

4.  Crystal structures of adenine phosphoribosyltransferase from Leishmania donovani.

Authors:  C L Phillips; B Ullman; R G Brennan; C P Hill
Journal:  EMBO J       Date:  1999-07-01       Impact factor: 11.598

5.  Purine nucleoside phosphorylase from human erythrocytes. I. Purification and properties.

Authors:  B K Kim; S Cha; R E Parks
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

6.  Cytoplsmic uridine phosphorylase of rat liver. Characterization and kinetics.

Authors:  A Kraut; E W Yamada
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

7.  Atomic structure at 2.5 A resolution of uridine phosphorylase from E. coli as refined in the monoclinic crystal lattice.

Authors:  A M Mikhailov; A N Popov; E V Blagova; E A Smirnova; B K Vainshtein; C Mao; Sh R Armstrong; S E Ealick; A A Komissarov
Journal:  FEBS Lett       Date:  1995-06-26       Impact factor: 4.124

8.  Crystal structure of calf spleen purine nucleoside phosphorylase in a complex with hypoxanthine at 2.15 A resolution.

Authors:  G Koellner; M Luić; D Shugar; W Saenger; A Bzowska
Journal:  J Mol Biol       Date:  1997-01-17       Impact factor: 5.469

9.  Purification and properties of an endothelial cell growth factor from human platelets.

Authors:  K Miyazono; T Okabe; A Urabe; F Takaku; C H Heldin
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

10.  Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine.

Authors:  J A Montgomery; S Niwas; J D Rose; J A Secrist; Y S Babu; C E Bugg; M D Erion; W C Guida; S E Ealick
Journal:  J Med Chem       Date:  1993-01-08       Impact factor: 7.446

View more
  64 in total

1.  Uridine phosphorylase from Trypanosoma cruzi: kinetic and chemical mechanisms.

Authors:  Rafael G Silva; Vern L Schramm
Journal:  Biochemistry       Date:  2011-09-27       Impact factor: 3.162

2.  Identification of the tautomeric form of formycin A in its complex with Escherichia coli purine nucleoside phosphorylase based on the effect of enzyme-ligand binding on fluorescence and phosphorescence.

Authors:  Jakub Włodarczyk; Gerasim Stoychev Galitonov; Borys Kierdaszuk
Journal:  Eur Biophys J       Date:  2003-12-04       Impact factor: 1.733

3.  Structural analysis of two enzymes catalysing reverse metabolic reactions implies common ancestry.

Authors:  Olga Mayans; Andreas Ivens; L Johan Nissen; Kasper Kirschner; Matthias Wilmanns
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

4.  Neighboring group participation in the transition state of human purine nucleoside phosphorylase.

Authors:  Andrew S Murkin; Matthew R Birck; Agnes Rinaldo-Matthis; Wuxian Shi; Erika A Taylor; Steven C Almo; Vern L Schramm
Journal:  Biochemistry       Date:  2007-04-04       Impact factor: 3.162

5.  Altered enthalpy-entropy compensation in picomolar transition state analogues of human purine nucleoside phosphorylase.

Authors:  Achelle A Edwards; Jennifer M Mason; Keith Clinch; Peter C Tyler; Gary B Evans; Vern L Schramm
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

6.  Physicochemical characterization of uridine phosphorylase from Shewanella oneidensis MR-1.

Authors:  N N Mordkovich; T N Safonova; V A Manuvera; V P Veiko; K M Polyakov; K S Alekseev; S N Mikhailov; V O Popov
Journal:  Dokl Biochem Biophys       Date:  2013-08-23       Impact factor: 0.788

7.  Structural and biochemical characterization of the nucleoside hydrolase from C. elegans reveals the role of two active site cysteine residues in catalysis.

Authors:  Ranjan Kumar Singh; Jan Steyaert; Wim Versées
Journal:  Protein Sci       Date:  2017-03-06       Impact factor: 6.725

8.  Preliminary crystallographic studies of purine nucleoside phosphorylase from the cariogenic pathogen Streptococcus mutans.

Authors:  Qiao Ming Hou; Xiang Liu; Erik Brostromer; Lan Fen Li; Xiao Dong Su
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

9.  Molecular modeling and dynamics studies of purine nucleoside phosphorylase from Bacteroides fragilis.

Authors:  Ivani Pauli; Luis Fernando Saraiva Macedo Timmers; Rafael Andrade Caceres; Luiz Augusto Basso; Diógenes Santiago Santos; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-01-27       Impact factor: 1.810

10.  Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.

Authors:  Teraya M Donaldson; María B Cassera; Meng-Chiao Ho; Chenyang Zhan; Emilio F Merino; Gary B Evans; Peter C Tyler; Steven C Almo; Vern L Schramm; Kami Kim
Journal:  Eukaryot Cell       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.